Development and evaluation of a vancomycin dosing nomogram to achieve the target area under the concentration-time curve. A retrospective study
| Autor: | Hideyuki Saito, Tomomi Katanoda, Kisato Nosaka, Koji Iwamura, Yuki Narita, Shoji Kondo, Kazutaka Oda, Hirofumi Jono, Yumi Hashiguchi |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male 0301 basic medicine Microbiology (medical) medicine.medical_specialty genetic structures 030106 microbiology Urology Renal function urologic and male genital diseases Young Adult 03 medical and health sciences 0302 clinical medicine Pharmacokinetics Vancomycin medicine Humans Pharmacology (medical) Trough Concentration 030212 general & internal medicine Dosing Aged Retrospective Studies Aged 80 and over Dose-Response Relationship Drug medicine.diagnostic_test business.industry Body Weight Retrospective cohort study Middle Aged Nomogram Anti-Bacterial Agents Nomograms Infectious Diseases Therapeutic drug monitoring Area Under Curve Creatinine Female Drug Monitoring business Glomerular Filtration Rate medicine.drug |
| Zdroj: | Journal of Infection and Chemotherapy. 26:444-450 |
| ISSN: | 1341-321X |
| DOI: | 10.1016/j.jiac.2019.11.009 |
| Popis: | Although the superiority of vancomycin dosing based on area under the concentration-time curve (AUC0-24) over that based on trough concentration has been reported, a dosing strategy to achieve the target AUC0-24 has yet to be developed. The objective of this study was to develop a convenient useable nomogram for vancomycin dosing to obtain the target AUC0-24 (400 μg h/mL). The nomogram was pharmacokinetically developed in a retrospective manner. The number of enrolled patients and concentrations was 166 and 309 for development of the nomogram, 99 and 181 for evaluation of the nomogram, respectively. The nomogram was developed as doses per personal body weight corresponding to each range of estimated glomerular filtration rate (eGFR), which was identified to be the covariate for vancomycin clearance by non-linear mixed effect modeling. The nomogram described the surrogate trough concentration for the target AUC0-24 was calculatedly different for each eGFR range (9.3–15.0 μg/mL). The rate of attainment of therapeutic range using surrogate trough concentration to obtain the target AUC0-24 was 63.8% in the evaluation period. We have developed and evaluated the first convenient useable nomogram of vancomycin dosing to obtain the target AUC0-24. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect